日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Administration of intratumoral GD2-directed interleukin-2 immunocytokine and local radiation therapy to activate immune rejection of spontaneous canine melanoma

肿瘤内注射GD2靶向白细胞介素-2免疫细胞因子并进行局部放射治疗,以激活犬自发性黑色素瘤的免疫排斥反应

Albertini, Mark R; Zuleger, Cindy L; Ranheim, Erik A; Shiyanbola, Oyewale; Sondel, Paul M; Morris, Zachary S; Eickhoff, Jens; Newton, Michael A; Ong, Irene M; Schwartz, Rene Welch; Hayim, Rubi; Kurzman, Ilene D; Turek, Michelle; Vail, David M

Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) setting

在对比(伴侣犬)环境中,原位疫苗接种和免疫调节靶向放射性核素联合免疫放射疗法的安全性和可行性

Kara Magee ,Ian R Marsh ,Michelle M Turek ,Joseph Grudzinski ,Eduardo Aluicio-Sarduy ,Jonathan W Engle ,Ilene D Kurzman ,Cindy L Zuleger ,Elizabeth A Oseid ,Christine Jaskowiak ,Mark R Albertini ,Karla Esbona ,Bryan Bednarz ,Paul M Sondel ,Jamey P Weichert ,Zachary S Morris ,Reinier Hernandez ,David M Vail

GS-9219/VDC-1101--a prodrug of the acyclic nucleotide PMEG has antitumor activity in spontaneous canine multiple myeloma

GS-9219/VDC-1101——一种非环状核苷酸PMEG的前药,对自发性犬多发性骨髓瘤具有抗肿瘤活性。

Thamm, Douglas H; Vail, David M; Kurzman, Ilene D; Babusis, Darius; Ray, Adrian S; Sousa-Powers, Noel; Tumas, Daniel B